Article information
Full text is only aviable in PDF
Bibliografía
[1.]
J.A. Como, W.E. Dismukes.
Oral azole drugs as systemic antifungal therapy.
N Engl J Med, 330 (1994), pp. 263-272
[2.]
R.M. Tucker, Y. Haq, D.W. Denning, D.A. Stevens.
Adverse events associated with itraconazole in 189 patients on chronic therapy.
J Antimicrob Chemother, 26 (1990), pp. 561-566
[3.]
R.M. Tucker, D.W. Denning, L.H. Hanson, et al.
Interaction of azoles with rifampin, phenytoin and carbamazepine: in vitro and clintcal observations.
Clin Infect Dis, 14 (1992), pp. 165-174
[4.]
D.W. Denning, R.M. Tucker, L.H. Hanson, D.A. Stevens.
Treatment of invasive aspergillosis with itraconazole.
Am J Med, 86 (1989), pp. 791-800
[5.]
B. DuPont.
Itraconazole therapy in aspergillosis. Study in 49 patients.
J Am Acad Dermatol, 23 (1990), pp. 607-614
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
